日韩中文字幕永久免费观看电剧_亚洲国产中文av网站1区_这里只有精品无卡顿_黄色影院在线观看视频_先锋音影亚洲自拍_熟妇高潮一区二区精品色欲_欧美巨大粗爽av在线观看_九九中文字幕天堂女人_亚洲国产日韩欧美综合久久_真实国产老熟女粗口
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.10.27
關(guān)于依諾肝素鈉注射液率先通過仿制藥一致性評(píng)價(jià)的公告
2020.10.27
2019年面向合格投資者公開發(fā)行公司債券（第一期）2020年度付息公告
2020.10.27
關(guān)于依諾肝素鈉注射液率先通過仿制藥一致性評(píng)價(jià)的公告
2020.10.26
2019年面向合格投資者公開發(fā)行公司債券（第一期）2020年度付息公告
2020.10.24
關(guān)于對(duì)全資子公司增資并參與投資設(shè)立醫(yī)療基金的公告
2020.10.24
第五屆董事會(huì)第三次會(huì)議決議公告
2020.10.23
五礦證券有限公司關(guān)于召開“19海普01”2020年第二次債券持有人會(huì)議的通知
2020.10.22
北京市中倫（深圳）律師事務(wù)所關(guān)于公司2019年面向合格投資者公開發(fā)行公司債券（第一期）20...
2020.10.22
2019年面向合格投資者公開發(fā)行公司債券（第一期）2020年第一次持有人會(huì)議決議公告
2020.10.14
五礦證券有限公司關(guān)于召開“19海普01”2020年第一次債券持有人會(huì)議的通知
第一頁(yè)
上一頁(yè)
28
29
30
31
32
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
